1 / 17

Creb Binding Protein

Creb Binding Protein. Ahmed Sadek. What is CBP?. CBP is a coactivator. TFs: CREB and CFos Highly related to p300. Discovered with CREB Integrator of STP. Transcription Factors/Coactivators. Coactivators needed for transcription factors TFs- sequence specific.

nieve
Download Presentation

Creb Binding Protein

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Creb Binding Protein Ahmed Sadek

  2. What is CBP? • CBP is a coactivator. • TFs: CREB and CFos • Highly related to p300. • Discovered with CREB • Integrator of STP

  3. Transcription Factors/Coactivators • Coactivators needed for transcription factors • TFs- sequence specific. Mark genes using coactivators and repressors • Coactivators function in several ways • Enzymatic activity transforms chromatin • CBP allows greater access of Proteins to DNA • Primary (enzymatic activity) and Secondary (no EA)

  4. Regulation through TFs and CAs • Trancriptional steps can be modified. • Already known: Transcription Factor concentrations. Using old techniques • Recently discovered: Coactivator concentrations. Using new techniques. • Coactivators hard to identify

  5. HATs • CBP is a histonacetyltransferase (HAT) • Acetylation (CH3 CO ) important regulator • May increase DNA binding, not always though. • Acetylation : histone tail and DNA weaken.

  6. CBP as a Disruptor • CBP disrupts coactivators and repressors. • Ex: CtBP (carboxyl terminal binding protein) • Interacts with Transcriptional corepressors. • CBP prevents this • CBP repression: wingless • Acetylating LEF-TCF-1 , cactivator B blocked

  7. CBP concentration is limited. • RR syndrome. • HIV gene expression: Interferon-a and tumor necrosis-a. • Stat-2 and NF-b • CBP contributing to transcriptional synergy • Recent evidence: promoters and TF binding sites , and CBP and multiple TFs

  8. . IFN-B enhanceosome complex. Creation of interaction surface for enhancer binding proteins. CBP: facilitator, acetylator of HMG1(Y). Derived from Rich Goodman et al

  9. Model of transcription. CBP role unclear. Enhanceosome formation, CBP- Mediator complex recruitment. Derived from Richard H Goodman Et Al.

  10. Not much known about CBP phosphorylation : CAM KINASE IV • Examples: E/cdk2- Activating genes in S. • PKA site : mediated increase of PIT-1 TF. Still mystery. • PKA and CREB • P44 MAP Kinase: 7x acetylation increase • Phosphoryltion tested • C-terminus : intramolecular conformational change must occur.

  11. CBP- P300 are very similar • Believed to be interchangeable. • Differences in development: Heterozygocity and blood problems and cancer. • Homozygous mutations are similar. • Herpesvirus protein vIRF activated by CBP but repressed by p300.

  12. Cystein/Histidine Rich dock TFs. • KIX- CREB. Contains sites for others. • Glutamine-rich C terminus- Coactivators. • No signature motifs for binding • Exception: CH3 , includes p53

  13. AT and Bromodomain • AT domain- Histone and nonhistone proteins • Not required by all TFs. • Basal transcriptional machinery contact. • Cofactors modify DNA. • Bromodomain • ATS and chromatin remodelling complexes. • Activation of Transcription and HA.

  14. KIX (blue) : simultaneous interaction • Small site: C-Myb (red) and (1 and 3 Helix bound, Important for blood development). • MLL: affinity increase. (green)

  15. Binary and ternary complex similar • *-1- *3 Helix (blue) , G1 and G2 Helix (orange)

  16. Structural Flexibility of MLL, no binding motif interaction (G2 and *3). • Change with different ligands, reducing affinity, when bound. • MLL Gene chromosomal translocation. Binding with CBP

  17. CBP and Disease CBP and Disease • RR syndrome : Retardation, deformities, hematological • Mice : 1 allele Hematoligical defect. • CBP investigation of tumor. • Interactions with repressors • E1A inhibiting activators, inhibits cell differentiation. • RR syndrome : Retardation, deformities, hematological • Mice : 1 allele Hematoligical defect. • CBP investigation of tumor. • Interactions with repressors • E1A inhibiting activators, inhibits cell differentiation.

More Related